Desmethylprodine (MPPP)


Status: Available in stock

Ready to send from Europe warehouse to

Price per unit
1 to 2 (gr)
USD 52.92
3 to 4 (gr)
USD 44.98
5 to 9 (gr)
USD 42.87
10 (gr) and more
USD 36.51

What is Desmethylprodine (MPPP)

Desmethylprodine or 1-methyl-4-phenyl-4-propionoxypiperidine (MPPP, Ro 2-0718) is an opioid analgesic drug developed in the 1940s by researchers at Hoffmann-La Roche. It is an analog of pethidine (meperidine). Chemically, it is a reversed ester of pethidine which has about 70% of the potency of morphine. Unlike its derivative prodine, it was not reported to exhibit optical isomerism. It was reported to have 30 times the activity of pethidine and a greater analgesic effect than morphine in rats, and it was demonstrated to cause central nervous system stimulation in mice.

History of Desmethylprodine (MPPP)

Desmethylprodine was first synthesized in 1947 at Hoffman-LaRoche Laboratories by Albert Ziering and John Lee. They found that it produced effects similar to morphine when administered to rats. Ziering had been searching for synthetic painkillers that were less addictive than morphine. The new drug was a slight variant of pethidine. This research produced the analgesic alphaprodine (Nisentil, Prisilidine), a very closely related compound.

updated at June 2023 - Tags: order Desmethylprodine, Desmethylprodine (MPPP)